使用[11C]SMW139 PET显像帕金森病促炎性小胶质细胞:一项多中心研究
本研究为多中心研究,纳入15例帕金森病患者和15例健康对照,使用[11C]SMW139 PET靶向P2X7受体显像促炎性小胶质细胞。结果显示帕金森病患者壳核和全皮层分布容积(VTp)显著高于健康对照,但VTp与运动症状严重程度或病程无显著关联。
要点
- 帕金森病患者壳核VTp显著高于健康对照(β=0.04,P=0.046)。
- 帕金森病患者全皮层VTp显著高于健康对照(β=0.04,P=0.043)。
- VTp与运动症状严重程度或病程均无显著关联。
主要发现
- 预设感兴趣区中,帕金森病患者壳核VTp显著高于健康对照(β=0.04;P=0.046)。
- 预设感兴趣区中,帕金森病患者全皮层VTp显著高于健康对照(β=0.04;P=0.043)。
- 探索性分析中,帕金森病患者眶额皮层VTp高于健康对照(β=0.04;P=0.041)。
- 帕金森病患者VTp与症状严重程度无显著关联:脑干β=-0.002,P=0.084;尾状核β=-0.002,P=0.164;壳核β=-0.002,P=0.265;全皮层β=-0.002,P=0.119。
- 帕金森病患者VTp与病程无显著关联:脑干β=-0.01,P=0.055;尾状核β=-0.005,P=0.282;壳核β=-0.01,P=0.113;全皮层β=-0.007,P=0.217。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Several translocator protein (TSPO) PET studies have shown increased glial cell density in Parkinson disease (PD); however, TSPO tracers are not able to differentiate between proinflammatory and antiinflammatory processes, information that is crucial for the development and evaluation of therapies. We used [11C]SMW139 PET to target the P2X7 receptor, which is expressed on proinflammatory microglia, to investigate proinflammatory signals in PD. Methods: Patients with PD (n = 15) and healthy controls (HCs) (n = 15) were included in this multicenter study. All participants underwent a 90-min [11C]SMW139 PET scan with continuous online and manual blood sampling. A 2-tissue compartment model with dual-input curves (both unchanged radiopharmaceutical [i.e., parent] and radiometabolites) was used to quantify [11C]SMW139. The distribution volume of the parent (V Tp) was considered the main parameter of interest. Differences in [11C]SMW139 V Tp between patients with PD and HCs were assessed using linear mixed models with post hoc testing. Regions of interest determined a priori included the putamen, caudate nucleus, brain stem, and whole cortex. Associations between motor symptom severity, as measured by the score on Part III (Motor Evaluation) of the Unified Parkinson's Disease Rating Scale, disease duration, and [11C]SMW139 V Tp were assessed using linear regression. Results: In the a priori regions of interest, patients with PD had a significantly higher V Tp in the putamen (β = 0.04; P = 0.046) and whole cortex (β = 0.04; P = 0.043) compared with those of HCs. In an exploratory analysis, patients with PD also had a higher V Tp in the orbitofrontal cortex (β = 0.04; P = 0.041) compared with that of HCs. There was no significant association between V Tp and symptom severity (brain stem: β = -0.002; P = 0.084; caudate nucleus: β = -0.002; P = 0.164; putamen: β = -0.002; P = 0.265; whole cortex: β = -0.002; P = 0.119) or disease duration (brain stem: β = -0.01; P = 0.055; caudate nucleus: β = -0.005; P = 0.282; putamen: β = -0.01; P = 0.113; whole cortex: β = -0.007; P = 0.217) in patients with PD. Conclusion: Patients with PD showed increased P2X7 receptor binding in the putamen and brain cortex, as assessed by [11C]SMW139 PET, suggesting the presence of increased levels of proinflammatory microglia.
引用
- Rikken RM, van de Giessen E, Brumberg J, et al. Imaging Proinflammatory Microglia in Parkinson Disease Using [11C]SMW139 PET: A Multicenter Study. J Nucl Med. 2025. PMID: 40774697. doi:10.2967/jnumed.125.269671
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。